Bioprosthetic Aortic Valve on the Move

Surgery is the mainstay of treatment for patients with acute aortic regurgitation (AR). Bioprosthetic valves (BVs) demonstrate an excellent profile in terms of hemodynamics and seem to be a good fit for patients with high risk of bleeding. Nonetheless, the durability of BVs is limited compared to mechanical valves; inevitably, BV degeneration may lead to significant complications requiring major surgical reintervention.